HELIX BIOMEDIX PEPTIDE STUDIED

October 1, 2003

Helix BioMedix completed a preliminary study designed to evaluate the efficacy of one the company's proprietary peptides, HB64, in reducing severity of mild to moderate acne symptoms.

Related Content:

Pediatric Dermatology